Haleon Plc Operating Income Over Time
| HLN Stock | USD 11.04 0.16 1.47% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Haleon Plc Performance and Haleon Plc Correlation. Will Biotechnology sector continue expanding? Could Haleon diversify its offerings? Factors like these will boost the valuation of Haleon Plc. Market participants price Haleon higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Haleon Plc data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.348 | Dividend Share 0.068 | Earnings Share 0.45 | Revenue Per Share | Quarterly Revenue Growth (0.01) |
The market value of Haleon plc is measured differently than its book value, which is the value of Haleon that is recorded on the company's balance sheet. Investors also form their own opinion of Haleon Plc's value that differs from its market value or its book value, called intrinsic value, which is Haleon Plc's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Haleon Plc's market value can be influenced by many factors that don't directly affect Haleon Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Haleon Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Haleon Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Haleon Plc's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Operating Income Analysis
Compare Haleon plc and related stocks such as Takeda Pharmaceutical, Agilent Technologies, and Cardinal Health Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TAK | 171.4 B | 265 B | 122.5 B | 139.3 B | (129.3 B) | 130.8 B | 155.9 B | 241.8 B | 205 B | 100.4 B | 509.3 B | 460.8 B | 490.5 B | 214.1 B | 342.6 B | 308.3 B | 226.9 B |
| A | 442 M | 1.1 B | 386 M | 419 M | 522 M | 615 M | 841 M | 904 M | 941 M | 846 M | 1.3 B | 1.6 B | 1.4 B | 1.5 B | 1.5 B | 1.7 B | 1.8 B |
| CAH | 8.4 M | 1.8 B | 996 M | 1.9 B | 2.2 B | 2.5 B | 2.1 B | 126 M | 2.1 B | (4.1 B) | 472 M | (607 M) | 752 M | 1.2 B | 2.3 B | 2.6 B | 2.7 B |
| RMD | 700 K | 294.4 M | 354.8 M | 405.1 M | 409.2 M | 429 M | 425.8 M | 541.8 M | 579.3 M | 809.7 M | 903.7 M | 1 B | 1.1 B | 1.3 B | 1.7 B | 1.9 B | 2 B |
| IQV | 395 M | 345.3 M | 396.4 M | 462.3 M | 590.4 M | 646.6 M | 642 M | 719 M | 741 M | 777 M | 731 M | 1.4 B | 1.8 B | 2 B | 2.2 B | 2.3 B | 2.4 B |
| ALC | 1.2 B | 401.1 M | 401.1 M | 401.1 M | 401.1 M | 401.1 M | 10 M | (77 M) | (248 M) | (187 M) | (482 M) | 580 M | 672 M | 1 B | 1.4 B | 1.6 B | 1.7 B |
| INSM | (8.1 M) | (61.7 M) | (42.4 M) | (55 M) | (87.4 M) | (117.5 M) | (173.4 M) | (188.9 M) | (307.3 M) | (235.2 M) | (265.2 M) | (375.1 M) | (457.3 M) | (709.6 M) | (878.3 M) | (790.4 M) | (750.9 M) |
| ZTS | 281 M | 684 M | 854 M | 821 M | 970 M | 1.1 B | 1.4 B | 1.7 B | 1.9 B | 2 B | 2.3 B | 2.8 B | 2.9 B | 3.1 B | 3.4 B | 3.9 B | 4.1 B |
| BDX | 137.7 M | 1.6 B | 1.3 B | 1.6 B | 1.1 B | 1.4 B | 1.5 B | 1.5 B | 1.8 B | 912 M | 2.2 B | 2.3 B | 2.1 B | 2.4 B | 2.6 B | 3 B | 3.1 B |
Haleon plc and related stocks such as Takeda Pharmaceutical, Agilent Technologies, and Cardinal Health Operating Income description
Operating Income is the amount of profit realized from Haleon plc operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Haleon plc is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Haleon plc | HLN |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | The Heights, Weybridge, |
| Exchange | New York Stock Exchange |
USD 11.04
Check out Haleon Plc Performance and Haleon Plc Correlation. To learn how to invest in Haleon Stock, please use our How to Invest in Haleon Plc guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Haleon Plc technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.